Therefore, specific inhibition of the IL‐6/JAK‐1/pSTAT3 pathway in astrocytes is a potential therapeutic approach to alleviate the progression of ischemic stroke caused by folic acid deficiency. Here, IL6 is linked to folate deficiency.